XML 15 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Revenue:    
Product sales $ 10,036,812 $ 10,841,047
Development revenue 1,621,877 1,098,374
Licensing revenue 18,678 50,701
Royalties 330,092 328,650
Total revenue 12,007,459 12,318,772
Cost of revenue:    
Cost of product sales 5,448,291 6,247,556
Cost of development revenue 771,475 528,185
Total cost of revenue 6,219,766 6,775,741
Gross profit 5,787,693 5,543,031
Operating expenses:    
Research and development 3,086,281 5,648,029
Selling, general and administrative 7,467,255 7,603,178
Total operating expenses 10,553,536 13,251,207
Operating loss (4,765,843) (7,708,176)
Other income 29,926 52,066
Net loss $ (4,735,917) $ (7,656,110)
Basic and diluted net loss per common share $ (0.03) $ (0.05)
Basic and diluted weighted average common shares outstanding 155,215,040 154,858,079